In 2023, the community pharmacy market in Switzerland had a value of generics standing at approximately 19.3. The forecast data for 2024 to 2028 illustrate a steady increase in value, growing from 19.7 in 2024 to 20.9 in 2028. This represents a consistent year-on-year growth, with variations of around 2% per year over the last two years, highlighting a robust growing market. The compound annual growth rate (CAGR) over the next five years is estimated at about 1.6%, signifying a stable yet continuous expansion of the generics market within the community pharmacy sector.

Future trends to watch for in this market include:

Potential policy changes affecting generic drug pricing and reimbursement.
Increasing consumer demand for cost-effective medication options.
Technological advancements in pharmaceutical manufacturing that could influence market dynamics.
Expansion of digital health platforms and services enhancing the accessibility of generics.